Botulism outbreak tied to ByHeart formula sickens more than 50 babies in 19 states, FDA says
The recent outbreak of infant botulism linked to ByHeart baby formula has raised serious concerns among federal health officials. The outbreak, which has now expanded to include all illnesses reported since the company began production in March 2022, has prompted investigations by the U.S. Food and Drug Administration and ByHeart to determine the root cause of the contamination.
According to an update shared by the FDA, it is possible that all ByHeart formula products ever produced could have been contaminated. As a result, the U.S. Centers for Disease Control and Prevention has broadened its probe to include any infant exposed to ByHeart formula since it first came on the market more than three years ago. The total number of infants affected by the outbreak now stands at 51 in 19 states, with the most recent illness reported on December 1. Fortunately, no deaths have been reported in connection with the outbreak.
Cases of infant botulism linked to ByHeart formula have been reported in various states, including California, Texas, and Massachusetts. The outbreak initially included 39 suspected or confirmed cases reported in 18 states, but an expanded definition has led to the identification of additional cases dating back to December 2023.
ByHeart, a New York-based manufacturer of organic infant formula, recalled all its products sold in the U.S. following the outbreak. The company, which accounts for about 1% of the U.S. infant formula market, had been selling approximately 200,000 cans of the product each month. The news that ByHeart products may have been contaminated for years has left many parents like Andi Galindo and Amy Mazziotti concerned and seeking accountability from the company.
In response to the outbreak, ByHeart officials have stated that they are cooperating with federal agencies to investigate the contamination further. The FDA has conducted inspections at ByHeart plants in Iowa and Oregon, where the formula is produced and packaged, but no results have been released yet. Previous inspection documents have revealed a history of contamination issues at ByHeart, including recalls in 2022 and a shutdown of a plant in Pennsylvania in 2023.
Infant botulism is a rare disease caused by ingesting botulism bacteria that produce toxins affecting the nervous system. Symptoms can include constipation, poor feeding, and difficulty breathing. The sole treatment for infant botulism is an IV medication called BabyBIG, developed by California’s infant botulism program. Families of affected babies have filed lawsuits against ByHeart, alleging negligence and seeking compensation for medical expenses and emotional distress.
Overall, the outbreak of infant botulism tied to ByHeart formula highlights the importance of stringent quality control measures in the production of infant products. Parents are advised to discontinue the use of recalled formula and seek medical attention if their child shows any symptoms of botulism.
